Minerva Neurosciences, Inc - stock earnings
NERV Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -9.0 million USD | ? USD |
| 2023Q3 | -7.8 million USD | ? USD |
| 2023Q2 | -6.2 million USD | ? USD |
| 2023Q1 | -3.6 million USD | ? USD |
| 2022Q4 | -8.4 million USD | ? USD |
| 2022Q3 | -8.6 million USD | ? USD |
| 2022Q2 | -8.6 million USD | ? USD |
| 2022Q1 | -9.8 million USD | ? USD |
| 2021Q4 | -21.3 million USD | ? USD |
| 2021Q3 | -9.2 million USD | 3.0 million USD |
| 2021Q2 | -10.6 million USD | 3442 USD |
| 2021Q1 | -8.8 million USD | 0 USD |
| 2020Q4 | -7.3 million USD | 0 USD |
| 2020Q3 | -8.1 million USD | 3 USD |
| 2020Q2 | 29.5 million USD | 41.2 million USD |
| 2020Q1 | -12.2 million USD | ? USD |
| 2019Q4 | -29.9 million USD | ? USD |
| 2019Q3 | -14.0 million USD | ? USD |
| 2019Q2 | -12.5 million USD | ? USD |
| 2019Q1 | -15.8 million USD | ? USD |
| 2018Q4 | -13.2 million USD | ? USD |
| 2018Q3 | -12.0 million USD | ? USD |
| 2018Q2 | -12.5 million USD | ? USD |
| 2018Q1 | -12.4 million USD | ? USD |
| 2017Q4 | 162088 USD | ? USD |
| 2017Q3 | -11.3 million USD | ? USD |
| 2017Q2 | -9.8 million USD | ? USD |
| 2017Q1 | -10.6 million USD | ? USD |
| 2016Q4 | -9.4 million USD | ? USD |
| 2016Q3 | -8.4 million USD | ? USD |
| 2016Q2 | -5.2 million USD | ? USD |
| 2016Q1 | -8.0 million USD | ? USD |
| 2015Q4 | -8.4 million USD | ? USD |
| 2015Q3 | -5.9 million USD | ? USD |
| 2015Q2 | -6.6 million USD | ? USD |
| 2015Q1 | -6.1 million USD | ? USD |
| 2014Q4 | -7.4 million USD | ? USD |
| 2014Q3 | -27.2 million USD | ? USD |
| 2014Q2 | -19.4 million USD | ? USD |
| 2014Q1 | -2.9 million USD | ? USD |
| 2013Q4 | -2.1 million USD | ? USD |
| 2013Q3 | -488193 USD | ? USD |
| 2013Q2 | -375953 USD | ? USD |
| 2013Q1 | -271330 USD | ? USD |
NERV Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -30.0 million USD | ? USD |
| 2022 | -39.0 million USD | ? USD |
| 2021 | -49.9 million USD | ? USD |
| 2020 | 1.9 million USD | 41.2 million USD |
| 2019 | -72.2 million USD | 41.2 million USD |
| 2018 | -50.2 million USD | ? USD |
| 2017 | -31.5 million USD | ? USD |
| 2016 | -31.0 million USD | ? USD |
| 2015 | -27.1 million USD | ? USD |
| 2014 | -56.9 million USD | ? USD |
| 2013 | -3.3 million USD | ? USD |
| 2012 | -1.6 million USD | ? USD |
NERV
Price: $2.37
52 week price:
Payout Ratio Range:
Earnings Per Share: -4.61 USD
P/E Ratio: -1.89
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 48300
Ebitda: -11.1 millionMarket Capitalization: 17.8 million